BTI320

DRUG2 trials

Sponsors

Chinese University of Hong Kong, Boston Therapeutics

Conditions

Pre-DiabetesType2 Diabetes Mellitus

Phase 2

BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes

CompletedNCT02358668

Chinese University of Hong KongPre-Diabetes

Start: 2015-03-30End: 2016-02-19Updated: 2017-04-25

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

CompletedNCT03655535

Boston TherapeuticsType2 Diabetes Mellitus

Start: 2018-09-19End: 2019-08-30Updated: 2020-09-25

Related Papers

Effects of BTI320 on Glycemic Control in Patients with Type 2 Diabetes

Diabetes & its Complications2021-09-30

A proof-of-concept study to evaluate the efficacy and safety of BTI320 on post-prandial hyperglycaemia in Chinese subjects with pre-diabetes.

2018-08-315 citations